FDA Inspection
Anderson & Collins Clinical Research Inc.Anderson & Collins Clinical Research Inc. – FDA Inspection, Mar 20, 2017
Record Details
This FDA Inspection record concerns Anderson & Collins Clinical Research Inc., with an inspection on March 20, 2017, issued by the New Jersey District Office, covering human drugs.
- Inspection Date
- March 20, 2017
- Product Type
- Human Drugs
View Company Profile
ID · c9e7a126-a8e9-4a08-8afd-809676b5c632
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1008182
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Anderson & Collins Clinical Research Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2012 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| October 21, 2008 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Anderson & Collins Clinical Research Inc.
- FDA Inspection 791930 - 2012-07-25
- FDA Inspection 543402 - 2008-10-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.